Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-01-01 @ 9:50 PM
Study NCT ID:
NCT06645704
Status:
COMPLETED
Last Update Posted:
2025-02-24
First Post:
2024-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label Phase 1 Study in Healthy Male Subjects to Investigate the Absorption, Metabolism and Excretion of [14C]-EP262 Following Single-Dose Oral Administration
Sponsor:
Escient Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-10
Completion Date Type:
ACTUAL
First Submit Date:
2024-10-15
First Submit QC Date:
None
Study First Post Date:
2024-10-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-02-24
Last Update Post Date Type:
ACTUAL